Amicus Therapeutics SG&A Expense (TTM) Insights

Amicus Therapeutics Inc (FOLD)

9.92 +0.01 (+0.10%) USD | NASDAQ | Jun 28, 16:00

9.90 -0.02 (-0.20%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	289.34M
December 31, 2023	275.27M
September 30, 2023	259.30M
June 30, 2023	240.93M
March 31, 2023	228.88M
December 31, 2022	213.04M
September 30, 2022	216.37M
June 30, 2022	215.20M
March 31, 2022	204.10M
December 31, 2021	192.71M
September 30, 2021	178.79M
June 30, 2021	170.54M
March 31, 2021	162.92M
December 31, 2020	156.41M
September 30, 2020	156.02M
June 30, 2020	157.85M
March 31, 2020	165.77M
December 31, 2019	169.86M
September 30, 2019	165.33M
June 30, 2019	157.51M
March 31, 2019	144.11M
December 31, 2018	127.20M
September 30, 2018	117.02M
June 30, 2018	106.80M
March 31, 2018	96.94M

Date	Value
December 31, 2017	88.67M
September 30, 2017	78.77M
June 30, 2017	74.59M
March 31, 2017	74.58M
December 31, 2016	71.15M
September 30, 2016	69.66M
June 30, 2016	67.56M
March 31, 2016	56.54M
December 31, 2015	47.27M
September 30, 2015	35.60M
June 30, 2015	25.49M
March 31, 2015	21.97M
December 31, 2014	20.72M
September 30, 2014	19.80M
June 30, 2014	19.17M
March 31, 2014	19.25M
December 31, 2013	18.89M
September 30, 2013	18.74M
June 30, 2013	19.10M
March 31, 2013	20.09M
December 31, 2012	19.36M
September 30, 2012	18.83M
June 30, 2012	18.67M
March 31, 2012	19.57M
December 31, 2011	19.88M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

156.02M

Minimum

Sep 2020

289.34M

Maximum

Mar 2024

198.81M

Average

185.75M

Median

SG&A Expense (TTM) Benchmarks